A049180 Stock Overview
A biotechnology company, provides bone graft materials, medical devices, and cosmeceuticals in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cellumed Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,668.00 |
| 52 Week High | ₩4,380.00 |
| 52 Week Low | ₩1,351.00 |
| Beta | 0.58 |
| 11 Month Change | -2.46% |
| 3 Month Change | 4.84% |
| 1 Year Change | -56.62% |
| 33 Year Change | -84.48% |
| 5 Year Change | -71.63% |
| Change since IPO | -84.19% |
Recent News & Updates
Shareholder Returns
| A049180 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -10.1% | -5.4% | 0.4% |
| 1Y | -56.6% | 19.0% | 2.8% |
Return vs Industry: A049180 underperformed the KR Medical Equipment industry which returned 19% over the past year.
Return vs Market: A049180 underperformed the KR Market which returned 2.8% over the past year.
Price Volatility
| A049180 volatility | |
|---|---|
| A049180 Average Weekly Movement | 10.3% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A049180 has not had significant price volatility in the past 3 months.
Volatility Over Time: A049180's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 101 | In-soo Yoo | www.cellumed.co.kr |
Cellumed Co.,Ltd., a biotechnology company, provides bone graft materials, medical devices, and cosmeceuticals in South Korea. The company offers CLnZyme, a mRNA enzyme; cosmeceuticals, such as FGF7 for skin regeneration and TGFß-1 for tissue regeneration; and electric motorcycles. It provides tissue bank products, such as celluderm powder, ultra, and HD implant for the skin; patellar tendon hemi whole, posterior tibialis, anterior tibialis, semitendinosus, gracilis, and peroneus longus tendons, and meniscus lateral and medial; cancellous bone chips and cortical cancellous dental bone powders; and femoral, tibia, radius, and ulna shafts, femur distal, tibia proximal, and cervical spacer bones.
Cellumed Co.,Ltd. Fundamentals Summary
| A049180 fundamental statistics | |
|---|---|
| Market cap | ₩82.11b |
| Earnings (TTM) | -₩30.24b |
| Revenue (TTM) | ₩111.87b |
0.7x
P/S Ratio-2.7x
P/E RatioIs A049180 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A049180 income statement (TTM) | |
|---|---|
| Revenue | ₩111.87b |
| Cost of Revenue | ₩100.27b |
| Gross Profit | ₩11.60b |
| Other Expenses | ₩41.84b |
| Earnings | -₩30.24b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -614.28 |
| Gross Margin | 10.37% |
| Net Profit Margin | -27.03% |
| Debt/Equity Ratio | 27.9% |
How did A049180 perform over the long term?
See historical performance and comparison